Stock Analiz

Nano-X Imaging Ltd. NNOX

Medical Electronics · IPO 2020 · data as of November 13, 2026

$0.32Market cap $25M
Open the interactive analysis →

Nano-X Imaging Ltd. (NNOX) is a healthcare company listed in the US with a market value of about $25M. In the twelve months to June 30, 2026 it had revenue of $16M and net income of -$117M, a net margin of -747.2%.

Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).

Key numbers: a 5-year average ROIC of -37%.

About Nano-X Imaging

Nano-X Imaging is listed in the US and classified in medical electronics, IPO year 2020. Revenue went from $1M in 2021 to $13M in 2025, growth of about 77.8% a year. It was profitable in 0 of the last 8 years in our data. It spends 148% of revenue on research and development.

Score: 1.0 / 5

Value0/5
Future growth3/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S1.6
P/B0.3
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-205.8%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)15.4%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-1544.7%
ROIC (5-yr avg.)-36.6%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 8 years

Fiscal yearTTM20252024202320222021202020192018
Revenue$16M$13M$11M$10M$9M$1M———
Net income-$117M-$75M-$54M-$61M-$113M-$62M-$44M-$23M-$2M
Free cash flow-$52M-$45M-$39M-$48M-$51M-$61M-$36M-$6M-$4M
EPS (diluted)$-1.72$-0.95$-0.68$-0.77$-1.44$-0.79$-0.56$-0.29$-0.02
Net margin-747.2%-576.1%-474.3%-613.6%-1320.2%-4739.1%———
ROIC—-51.7%-28.7%-30.5%-51.5%-20.6%-14.9%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 3 analysts is $4.13, 1183% above the current price; targets range from $3.00 to $5.00; the consensus rating is “none”; expected EPS is $-0.60 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does Nano-X Imaging pay a dividend?

Not currently.

Is Nano-X Imaging a good stock to buy?

We do not give buy or sell advice. Nano-X Imaging scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.